Background & Aims: Somatostatin receptor subtype 2 (sst(2)) agonists i
nhibit gastric secretion. The role of sst(2) in the regulation of acid
secretion was assessed using sst(2) knockout mice and urethane to ind
uce somatostatin release. Methods: Acid secretion was monitored every
10 minutes by gastric perfusion and backtitration of perfusates in fas
ted, urethane-anesthetized C57/ 129 sst(2) (-/-) mice and wild-type (/+) mice. The ileal vein was cannulated for drug injection. Intragastr
ic pH and serum gastrin were monitored 1 hour after anesthesia without
perfusion. Results: Gastric pH values were lower in sst(2) (-/-) mice
(3.8 +/- 0.3) than in wild-type mice (7.1 +/- 0.1, P < 0.05), and the
re was no difference in gastrin levels. Basal acid output per 2 hours
was 10-fold higher in sst(2) knockout mice compared with wild-type mic
e. The gastrin antibody abolished the high basal acid secretion in sst
(2) (-/-) mice and had no effect in wild-type mice. The somatostatin a
ntibody increased basal secretion by LF-fold in wildtype and had no ef
fect in knockout mice. Somatostatin 14 or the sst(2) agonist DC 32-87
inhibited pentagastrin-stimulated acid secretion in wild-type mice, bu
t did not alter basal secretion in knockout mice. Conclusions: These r
esults indicate that sst(2) is the main subtype whereby endogenous som
atostatin suppresses gastric acid secretion through inhibition of gast
rin action.